Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...

The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...

DexCom faces significant headwinds, including slower customer growth and increased competition. Learn more on DXCM here.

Dexcom designed Stelo for adults 18 years and older who are not taking any insulin therapies—a group that includes about 25 million people living with Type 2 diabetes in the U.S. It's also ...

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third ...

Learn More About one in three Americans, or 125 million people, are prediabetic or have Type 2 diabetes. Dexcom‘s Stelo glucose monitor is for those people and I’ve found it works pretty well.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

Shelomi Sanders, the daughter of Colorado Football head coach Deion Sanders, goes in-depth with Natalie Esquire and ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...